Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fanny Mingant, Romain Didier, Martine Gilard, Françoise Martin, Pierre-Philippe Nicol, Valérie Ugo, Eric Lippert & Hubert Galinat. (2018) Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor. Platelets 29:3, pages 257-264.
Read now
Read now
Petra Jilma-Stohlawetz, Franz Ratzinger, Christian Schörgenhofer, Bernd Jilma & Peter Quehenberger. (2016) Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow. Scandinavian Journal of Clinical and Laboratory Investigation 76:3, pages 249-255.
Read now
Read now
Zufar Gabbasov, Jan Sabo, Daniel Petrovic, Nieves Martell-Claros, Angela Zagatina, Igor Mrdovic, Rachele Ciccocioppo, Giuseppina Cristina Cangemi, Jan Klimas & Peter Kruzliak. (2015) Impact of platelet phenotype on myocardial infarction. Biomarkers 20:1, pages 17-25.
Read now
Read now
A. Komosa, J. M. Siller-Matula, J. Kowal, M. Lesiak, A. Siniawski, M. Mączyński, M. Michalak, T. Mularek-Kubzdela & S. Grajek. (2015) Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb. Platelets 26:1, pages 43-47.
Read now
Read now
Jie Guan, Yulong Cong, Junwei Ren, Yuan Zhu, Li Li, Xinli Deng & Jie Bai. (2015) Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals. Platelets 26:1, pages 25-30.
Read now
Read now
Articles from other publishers (14)
Simon Davidson. 2023. Hemostasis and Thrombosis. Hemostasis and Thrombosis
381
402
.
O. S. Melnichnikova, I. A. Nazarova, O. V. Sirotkina, A. V. Panov, I. T. Abesadze, M. Z. Alugishvili, N. L. Lokhovinina & T. V. Vavilova. (2022) Integral Tests of the Hemostasis System in Assessing the Efficiency of Acetylsalicylic Acid in Patients with Ischemic Heart Disease. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 16:1, pages 60-65.
Crossref
Crossref
O.S. Melnichnikova, I.A. Nazarova, O.V. Sirotkina, A.V. Panov, I.T. Abesadze, M.Z. Alugishvili, N.L. Lokhovinina & T.V. Vavilova. (2021) Integral tests of the hemostasis system in assessing the efficiency of acetylsalicylic acid in patients with ischemic heart disease. Biomeditsinskaya Khimiya 67:5, pages 427-433.
Crossref
Crossref
Paul A. Gurbel, Udaya S. Tantry, Kevin P. Bliden, Richard Fisher, Sivaprasad Sukavaneshvar, Jeffrey Dahlen & Philip C. Speros. (2021) Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists. Journal of Thrombosis and Thrombolysis 52:1, pages 272-280.
Crossref
Crossref
Cen Yue, Zhiwei Lin, Congxia Lu & Hanshui Chen. (2021) Efficacy of Monitoring Platelet Function by an Automated PL-12 Analyzer During the Treatment of Acute Cerebral Infarction With Antiplatelet Medicine. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962110011.
Crossref
Crossref
Mohammad Algahtani & Stan Heptinstall. (2017) Novel strategies for assessing platelet reactivity. Future Cardiology 13:1, pages 33-47.
Crossref
Crossref
Minka J.A. Vries, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W.M. Verhezen, Arina J. ten Cate-Hoek, Hugo ten Cate, Yvonne M.C. Henskens & Paola E.J. van der Meijden. (2017) Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients. European Heart Journal - Cardiovascular Pharmacotherapy 3:1, pages 11-17.
Crossref
Crossref
Rose J. Brazilek, Francisco J. Tovar-Lopez, Angus K. T. Wong, Huyen Tran, Amanda S. Davis, James D. McFadyen, Zane Kaplan, Sanjeev Chunilal, Shaun P. Jackson, Harshal Nandurkar, Arnan Mitchell & Warwick S. Nesbitt. (2017) Application of a strain rate gradient microfluidic device to von Willebrand's disease screening. Lab on a Chip 17:15, pages 2595-2608.
Crossref
Crossref
Marie Lordkipanidzé, Derek So & Jean-François Tanguay. (2016) Platelet function testing as a biomarker for efficacy of antiplatelet drugs. Biomarkers in Medicine 10:8, pages 903-918.
Crossref
Crossref
A. Komosa, J.M. Siller-Matula, M. Lesiak, M. Michalak, J. Kowal, M. Mączyński, A. Siniawski, T. Mularek-Kubzdela, S. Wiśniewski & S. Grajek. (2016) Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention. Thrombosis Research 138, pages 49-54.
Crossref
Crossref
Minka J. A. Vries, Paola E. J. van der Meijden, Yvonne M. C. Henskens, Arina J. ten Cate-Hoek & Hugo ten Cate. (2017) Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. Thrombosis and Haemostasis 115:01, pages 7-24.
Crossref
Crossref
M. J. A. Vries, P. E. J. van der Meijden, Y. M. C. Henskens, A. J. ten Cate-Hoek & H. ten Cate. (2015) Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. Thrombosis and Haemostasis 114:6.
Crossref
Crossref
Eva-Luise Hobl, Ulla Derhaschnig, Christa Firbas, Christian Schoergenhofer, Michael Schwameis & Bernd Jilma. (2013)
Reversal strategy in antagonizing the P2Y
12
-inhibitor ticagrelor
. European Journal of Clinical Investigation 43:12, pages 1258-1261.
Crossref
Crossref
Eva-Luise Hobl, Bernd Jilma, Ulla Derhaschnig, Christian Schoergenhofer, Michael Schwameis & Petra Jilma-Stohlawetz. (2013)
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y
12
-inhibition after ticagrelor intake
. Cytometry Part B: Clinical Cytometry, pages n/a-n/a.
Crossref
Crossref